Office gynecology におけるマイクロ波子宮内膜アブレーションによる粘膜下筋腫の治療

書誌事項

タイトル別名
  • Microwave endometrial ablation for submucous myoma in office gynecology

この論文をさがす

抄録

The aim of the study is to evaluate the safety and effectiveness of microwave endometrial ablation (MEA) in women with submucous myomas for office-based gynecology. Thirty outpatients (average age : 44.6 years) who hoped to avoid hysterectomy received MEA for treatment of menorrhagia due to submucous myomas. The patients were divided into two groups according to the maximal myoma size. Group A (21 cases) in which node is less than 3 centimeters treated by MEA. Group B (9 cases) in which node is over 3 centimeters was treated by MEA with transcervical microwave myolysis (TCMM). <br>    The mean operation time were in Group A; 17.7 and in Group B; 18.5 min. The blood loss during a monthly menstrual period decreased in Group A; seventeen (80.9%) and Group B; eight (88.8%) patients to less than 20%, Group A; three (14.2%) and Group B; one (11.1%) patient to less than 50%. Menorrhagia remained in Group A; one (4.7%) and in Group B; no patient after treatment. Three patients (14.2%) of Group A and one (11.1%) of Group B had mild endometritis within a month after treatment. The average VAS score regarding feelings of satisfaction for MEA were 8.8 (Group A) and 9.2 (Group B)(full score=10). MEA with TCMM is feasible for treatment of menorrhagia due to submucous myomas in various size and it may be useful for a office day surgical procedure that is minimally invasive for who hoped to avoid hysterectomy.

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (4)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ